Novavax vaccine shows 96 per cent efficacy against original coronavirus, 86 per cent against UK variant Read more
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase III trial Read more
Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports Read more